16 earlier Form 4 trades (code P or S) here by this insider (16 buys), the last on Nov 14, 2025.
+14.6% median (+14.7% mean) 90-day return after 14 previous buys.
The trade is 3.0% of the 331,181 shares held after it.
No other insider bought within 30 days.
16 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director RATAJCZAK DONALD R bought about $28.0K of CRWS on Nov 17, 2025, the largest insider purchase at the company since 2024; 16 funds added in the latest 13F quarter.
14 earlier Form 4 trades (code P or S) here by this insider (14 buys), the last on Aug 16, 2024.
+16.0% median (+15.1% mean) 90-day return after 12 previous buys.
The trade is 3.2% of the 311,181 shares held after it.
No other insider bought within 30 days.
16 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director RATAJCZAK DONALD R bought about $27.5K of CRWS on Nov 13, 2025, the largest insider purchase at the company since 2024; 16 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Aug 19, 2024.
-4.1% median (-4.1% mean) 90-day return after 2 previous buys.
The trade is 14.8% of the 80,294 shares held after it.
1 other insider bought within 30 days.
16 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director NIE ZENON S bought about $56.5K of CRWS on Sep 9, 2024, the largest insider purchase at the company since 2023; 1 other insider bought within 30 days and 16 funds added in the latest 13F quarter.
33 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CRWS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
RATAJCZAK DONALD R
Filed 2026-08-20
$44.2K
CRWS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
North Star Dividend Fund
$485.0K position · as of 2026-05-31
0.5%
Pinnacle Value Fund
$174.5K position · as of 2026-06-30
0.5%
Omni Small-Cap Value Fund
$144.4K position · as of 2026-06-30
0.0%
EA Bridgeway Omni Small-Cap Value ETF
$173.0K position · as of 2026-06-30
0.0%
U.S. SMALL CAP VALUE PORTFOLIO
$306.9K position · as of 2026-07-31
0.0%
LVIP Dimensional U.S. Core Equity 2 Fund
$9.5K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$475.4K
$342.8K
$266.5K
-41%
n/a
2024
$912.3K
$770.7K
$447.0K
-26%
n/a
2023
$430.8K
$136.4K
$418.4K
-5%
n/a
2022
$574.1K
$480.6K
$368.4K
-6%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows 16 funds added last quarter, $44.2K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$83.6M
four quarters, 2025-06-30 to 2026-06-28
Revenue, TTM CRWS
FY Mar 2026
$82.3M
FY Mar 2025
$87.2M
FY Mar 2024
$87.6M
FY Apr 2023
$75.1M
FY Apr 2022
$87.4M
Jun 2026
$16.8M
Mar 2026
$22.4M
Dec 2025
$20.7M
Sep 2025
$23.7M
Jun 2025
$15.5M
Mar 2025
$23.2M
Dec 2024
$23.4M
Sep 2024
$24.5M
At each fiscal year end
Single quarter
Net margin, TTM
+6.0%
net income over revenue, 2025-06-30 to 2026-06-28
Net margin, TTM CRWS
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
+5.2%
FY Apr 2023
+7.5%
FY Apr 2022
+11.4%
Jun 2026
+12.3%
Mar 2026
+1.3%
Dec 2025
+7.3%
Sep 2025
+4.9%
Jun 2025
-7.1%
Mar 2025
-46.4%
Dec 2024
+3.8%
Sep 2024
+3.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$7.6M
operating cash flow minus capex, 2025-06-30 to 2026-06-28
Free cash flow, TTM CRWS
FY Mar 2026
$7.4M
FY Mar 2025
$8.9M
FY Mar 2024
$6.3M
FY Apr 2023
$6.9M
FY Apr 2022
$7.7M
Jun 2026
$5.4M
Mar 2026
$926.0K
Dec 2025
$2.3M
Sep 2025
-$1.0M
Jun 2025
$5.2M
Mar 2025
$2.6M
Dec 2024
-$220.0K
Sep 2024
-$1.2M
At each fiscal year end
Single quarter
Debt to equity
0.24x
long-term 2026-06-28 plus current 2026-06-28; equity 2026-06-28
Debt to equity CRWS
FY Mar 2026
0.36x
FY Mar 2025
0.47x
FY Mar 2024
0.16x
FY Apr 2023
0.26x
FY Apr 2022
0.00x
Jun 2026
0.24x
Mar 2026
0.36x
Dec 2025
0.42x
Sep 2025
0.43x
Jun 2025
0.37x
Mar 2025
0.47x
Dec 2024
0.41x
Sep 2024
0.41x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.89x
TTM operating cash flow over long-term 2026-06-28 plus current 2026-06-28
Cash flow to debt CRWS
FY Mar 2026
0.59x
FY Mar 2025
0.53x
FY Mar 2024
0.87x
FY Apr 2023
0.61x
FY Apr 2022
n/a
Jun 2026
0.89x
Mar 2026
0.59x
Dec 2025
0.60x
Sep 2025
0.44x
Jun 2025
0.51x
Mar 2025
0.53x
Dec 2024
0.48x
Sep 2024
0.46x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.8%
TTM net income over average of 2025-06-30 and 2026-06-28
Return on equity CRWS
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
+9.1%
FY Apr 2023
+11.9%
FY Apr 2022
+22.6%
Jun 2026
+12.8%
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
-22.9%
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+6.9%
TTM net income over average of 2025-06-29 and 2026-06-28
Return on assets CRWS
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
+5.3%
FY Apr 2023
+7.5%
FY Apr 2022
+16.8%
Jun 2026
+6.9%
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
-13.3%
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+7.8%
operating income after a 26.3% effective tax rate, over long-term 2026-06-28 plus current 2026-06-28 plus average of 2025-06-30 and 2026-06-28 minus cash
Return on invested capital CRWS
FY Mar 2026
+1.4%
FY Mar 2025
n/a
FY Mar 2024
+9.5%
FY Apr 2023
+9.3%
FY Apr 2022
+19.4%
Jun 2026
+7.8%
Mar 2026
+1.4%
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
+4.6%
Sep 2024
+5.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+9.1%
operating income (EBIT proxy) over average of 2025-06-29 and 2026-06-28 minus current liabilities
Return on capital employed CRWS
FY Mar 2026
+1.8%
FY Mar 2025
-16.2%
FY Mar 2024
+9.2%
FY Apr 2023
+11.4%
FY Apr 2022
+22.0%
Jun 2026
+9.1%
Mar 2026
+1.8%
Dec 2025
-19.3%
Sep 2025
-16.6%
Jun 2025
-19.8%
Mar 2025
-16.2%
Dec 2024
+5.5%
Sep 2024
+6.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing CRWS
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Apr 2023
8.73x
FY Apr 2022
9.85x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$35.3M
market value at close 2026-10-26 on 2026-08-05 shares, plus long-term 2026-06-28 plus current 2026-06-28, minus cash 2026-06-28
Enterprise value CRWS
FY Mar 2026
$42.2M
FY Mar 2025
$56.3M
FY Mar 2024
$59.5M
FY Apr 2023
$69.2M
FY Apr 2022
$63.9M
Jun 2026
$39.7M
Mar 2026
$42.2M
Dec 2025
$42.6M
Sep 2025
$46.2M
Jun 2025
$43.2M
Mar 2025
$56.3M
Dec 2024
$66.7M
Sep 2024
$68.4M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+29.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield CRWS
FY Mar 2026
+26.2%
FY Mar 2025
+23.3%
FY Mar 2024
+12.1%
FY Apr 2023
+11.9%
FY Apr 2022
+11.8%
Jun 2026
+25.0%
Mar 2026
+26.2%
Dec 2025
+31.8%
Sep 2025
+21.3%
Jun 2025
+21.6%
Mar 2025
+23.3%
Dec 2024
+19.6%
Sep 2024
+17.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing CRWS
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Apr 2023
0.27x
FY Apr 2022
0.31x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CRWS ranks highest on risk and compliance (73rd percentile) and financial health (62nd), and lowest on institutional and government (22nd), among Consumer Goods peers.
Profitability
54
Inputs
Return on equity+12.8% · 62 pct, sector of 105
Return on assets+6.9% · 72 pct, sector of 124
Return on invested capital+7.8% · 18 pct, sector of 51
Return on capital employed+9.1% · 63 pct, sector of 108
Financial health
62
Inputs
Debt to equity0.24x · 52 pct, sector of 112
Cash flow to debt0.89x · 73 pct, sector of 96
Growth
24
Inputs
Revenue growth, YoY-5.7% · 24 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
22
Inputs
Funds adding, latest quarter16 · 22 pct, sector of 123
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
73
Inputs
Short interest, % of float+0.3% · 83 pct, sector of 157
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 102
New text in Risk Factors, latest 10-K+18.2% · 35 pct, sector of 111
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CRWS filings, in plain words
Are there planned insider sales of CRWS?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $44.2K of stock; the latest, by RATAJCZAK DONALD R, was filed 2026-08-20.
Read the full summary
Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $44.2K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.